Cost of developing new drugs may be lower than industry claims: trial

Drug companies are unambiguously out of control. Some of these new molecules don't even need to be invented, they're just legally distinct repackaging of something they can't gouge on anymore. These companies could, if they had an incentive to do so, research effective off-label uses of existing drugs, say. But there's no money in that. There is a ton of money in making legally distinct "new" drugs that do the same thing as newly-generic drugs. It's unacceptable what they get away with.

Covid ought to have been the final straw that brought all sides together to do something about drug companies.

What’s stopping people from using the old packaging when the patent expires?

They stop making it, and pay generic manufacturers not to.

https://www.nbcnews.com/business/business-news/drug-firms-st...

> Known as "reverse settlement payments," or "pay-to-delay" deals, the financial arrangements are a unique but common practice in the pharmaceutical industry. Essentially, they allow drug manufacturers in some instances to pay competitors not to manufacture generic versions of their products, thereby ensuring that they maintain patent protection for as long as possible.